Orphazyme
Presence
Orphazyme is a company listed under the stock ticker ORPHA (DK).
Executives
View the org chart displaying its 4 main executives
Most searched biographies at Orphazyme
- Jakob Bendtsen, Board Member and Chief Executive Officer
- Andrew Mercieca, Director
- Bo Jesper Hansen, Deputy Chairman of The Board
Popular executive movements at Orphazyme
- Jakob Bendtsen who is Board Member, will be promoted to Board Member and Chief Executive Officer on Oct. 1, 2023 (posted on September 21 2023).
Create your alert
to follow the executive moves at Orphazyme.
Biotechnology
Orphazyme has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- BioNTech has just announced a $145 Million fundraising (posted on June 5 2024).
- Merck has announced the acquisition of EyeBio (posted on May 31 2024).
- Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
Popular contacts in Biotechnology
News
Press releases by Orphazyme
- ORPHAZYME ESTABLISHES U.S. HEADQUARTERS IN CHICAGO AS THE COMPANY PREPARES FOR COMMERCIALIZATION — Orphazyme
- ORPHAZYME SUBMITS EUROPEAN MARKETING AUTHORISATION APPLICATION FOR ARIMOCLOMOL FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C — Orphazyme
- END OF STABILIZATION PERIOD — Orphazyme
- STABILIZATION MEASURES TAKEN — Orphazyme
- ORPHAZYME ACCELERATES ARIMOCLOMOL PRE-LAUNCH ACTIVITIES AND UPDATES FINANCIAL OUTLOOK FOR 2020 — Orphazyme
- STABILIZATION MEASURES TAKEN — Orphazyme
- View more press releases Close
Social media about Orphazyme
- Orphazyme on Wikipedia, Google News & Yahoo Finance
- Orphazyme on LinkedIn, Twitter & YouTube
